Table 2.
Operators performance based on composite detection rate
| Operator | Center | CDR [%] |
UGN [%] |
EBR [%] |
CDR group |
UGN [%] |
OR for UGN detection [95% CI] | p value | Biopsy rate |
|---|---|---|---|---|---|---|---|---|---|
| 1 | A | 54.0% | 5.8% | 81.3% |
Group 4 > 26% |
6.0% | 4.4 [2.2 − 9.0] | < 0.001 | 80.9% |
| 2 | A | 42.8% | 4.8% | 89.7% | |||||
| 3 | A | 40.7% | 7.1% | 61.9% | |||||
| 4 | A | 36.7% | 5.1% | 88.8% | |||||
| 5 | B | 25.7% | 0.8% | 51.3% |
Group 3 17.1–26% |
1.9% | 1.2 [0.5 − 2.8] | 0.67 | 54.7% |
| 6 | B | 24.8% | 1.5% | 64.9% | |||||
| 7 | B | 17.8% | 1.8% | 31.4% | |||||
| 8 | C | 17.5% | 4.8% | 98.4% | |||||
| 9 | B | 16.9% | 0.5% | 43.3% |
Group 2 10–17% |
1.6% | 1.1 [0.4 − 2.7] | 0.87 | 64.9% |
| 10 | C | 16.1% | 1.8% | 78.6% | |||||
| 11 | A | 15.4% | 1.5% | 53.8% | |||||
| 12 | C | 12.6% | 2.2% | 74.8% | |||||
| 13 | C | 10.5% | 1.9% | 93.3% | |||||
| 14 | C | 9.9% | 0.5% | 83.3% |
Group 1 < 10% |
1.4% | 1 | Reference | 60.6% |
| 15 | B | 9.6% | 0.9% | 36.0% | |||||
| 16 | C | 7.4% | 1.4% | 51.2% | |||||
| 17 | A | 3.4% | 3.4% | 26.7% |
CDR composite detection rate, UGN upper gastrointestinal neoplasm, EBR endoscopist biopsy rate, OR odds ratio, CI confidence interval